Improvement in symptoms and signs in the forefoot of patients with rheumatoid arthritis treated with anti‐TNF therapy
Catherine Bowen(University of Southampton), Nigel Arden(Nuffield Orthopaedic Centre), Madeleine Sampson(NIHR Southampton Biomedical Research Centre), K. C. Dewbury(NIHR Southampton Biomedical Research Centre), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Lindsey Hooper(University Hospital Southampton NHS Foundation Trust), Jane Burridge(University of Roehampton), Sally Sawyer
Cited by 18
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k